Risk of Osteoporosis raised by chemotherapyChemotherapy for lymphoma should be recognized as a risk factor for the development of osteoporosis, according to Dr. Bhaskar Dasgupta in a poster session at the annual meeting of the British Society for Rheumatology.

Dr. Dasgupta, director of rheumatology, Southend Hospital NHS Trust, Westcliff on Sea, England, said patients with lymphoma have greatly improved survival rates because of advances in treatment, but their quality of life may be compromised by long-term complications of chemotherapy.

Osteoporosis is a complication that can result from treatment with alkylating agents and the steroids that are usually given with chemotherapy.